Table 1.
Demographic Characteristics of Sample of DRIVE Cohort PWID
| Cohort Entry 1 (2016) | Cohort Entry 2 (2017) | |||||||
|---|---|---|---|---|---|---|---|---|
| Baseline | M6* | M12* | M18* | M24* | Baseline | M18* | M24* | |
| Total Sample (N) | 412 | 331 | 302 | 274 | 269 | 233 | 176 | 169 |
| N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
| Gender+ | ||||||||
| Male | 387 (94) | 224 (96.1) | ||||||
| Female | 23 (6) | 9 (3.9) | ||||||
| Median Age (SD)+ | 39.9 (6.29) | 40.7 (6.68) | ||||||
| Depression | 137 (33.3) | 51 (15.4) | 33 (10.9) | 26 (9.5) | 30 (11.2) | 55 (23.6) | 15 (8.5) | 19 (11.2) |
| Nervous/Anxiety+ | 145 (35.2) | 68 (29.2) | ||||||
| History of Arrest | 13 (3.9) | 21 (7.0) | 7 (2.6) | 14 (5.2) | 5 (2.8) | 12 (7.1) | ||
| Substance Use Characteristics | ||||||||
| Alcohol Use | 250 (60.7) | 194 (59.2) | 187 (61.9) | 151 (55.1) | 138 (51.4) | 135 (58) | 104 (59.1) | 95 (56.2) |
| Morphine positive urine toxicology | 410 (99.5) | 331 (100) | 186 (61.6) | 163 (60.6) | 233 (100) | 176 (100) | 105(62.1) | |
| Street Methadone+ | 162 (39.3) | 68 (29.2) | ||||||
| HCV Seropositive | 377 (91.5) | 306 (92.4) | 279 (92.4) | 256 (93.4) | 246 (91.4) | 187 (80.3) | 152 (86.4) | 150 (88.8) |
| Methamphetamine Use (days) | ||||||||
| 0 | 202 (61) | 237 (71.6) | 227 (75.2) | 211 (77) | 193 (71.7) | 120 (52) | 124 (70.5) | 119 (70.4) |
| 1–19 | 112 (33.8) | 79 (23.9) | 67 (22.2) | 56 (20.4) | 68 (25.3) | 52 (29.5) | 48 (27.3) | 46 (27.2) |
| 20+ | 17 (5.1) | 15 (4.5) | 8 (2.6) | 7 (2.6) | 8 (3) | 4 (2.3) | 4 (2.3) | 4 (2.4) |
| ART Adherence Score (0–10) | ||||||||
| 0–8 | 43 (10.4) | 53 (17.6) | 22 (7.9) | 20 (7.9) | 13 (5.1) | 53 (22.7) | 9 (7.3) | 5 (4) |
| 9–10 | 170 (41.3) | 249 (82.4) | 256 (92.1) | 233 (92.1) | 240 (94.9) | 179 (76.8) | 114 (92.7) | 120 (96) |
| Viral Suppression | ||||||||
| Yes | 307 (74.5) | 256 (77.3) | 255 (84.4) | 230 (83.9) | 233 (86.6) | 179 (76.8) | 152 (86.4) | 147 (87) |
| No | 99 (24) | 69 (20.8) | 47 (15.6) | 44 (16.1) | 34 (12.6) | 53 (22.7) | 17 (9.7) | 21 (12.4) |
*
M6=month 6 follow-up, M12=month 12 follow-up, M18=month 18 follow-up, & M24=month 24 follow-up
+
only collected at baseline visit